Company Profile

Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Companyâ€™s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industryâ€™s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.

Employees

292

Sector

Advanced Medical Equipment & Technology

More about the company

Market Closed - OTC Markets 02:44:37 07/04/26 am AEST			5-day change	1st Jan Change
0.3105 ^USD	+2.56%		-0.00%	-79.02%

14/05	Venus Concept Inc. Announces Senior Management Changes	CI
09/04	Venus Concept Inc. announced that it has received $1.5 million in funding	CI

14/05	Venus Concept Inc. Announces Senior Management Changes	CI
09/04	Venus Concept Inc. announced that it has received $1.5 million in funding	CI
26/03	Venus Concept Inc. announced that it expects to receive $1.5 million in funding	CI
11/02	Venus Concept Inc.(NasdaqCM:VERO) dropped from S&P TMI Index	CI
06/02	Venus Concept Inc.(OTCPK:VERO) dropped from NASDAQ Composite Index	CI
22/01	Top Midday Decliners	MT
21/01	Venus Concept announces intention to voluntary delist from Nasdaq and deregister with SEC	RE
21/01	Top Premarket Gainers	MT
21/01	Venus Concept Inc. Announces Voluntary Delisting from NASDAQ and Deregistration with SEC to Enhance Financial Efficiency	CI
20/01	Top Premarket Decliners	MT
16/01	Top Premarket Gainers	MT
16/01	Madryn Asset Management Engages with Venus Concept Inc. on Cost Reduction and Strategic Initiatives Amid Debt Restructuring Efforts	CI
08/01	Venus Concept Inc - On Dec 31, co & its unit enter consent agreement with Madryn Health Partners & others - SEC filing	RE

06/10/23	BTIG Downgrades Venus Concept to Neutral From Buy	MT
29/03/23	Ladenburg Thalmann Adjusts Price Target on Venus Concept to $2.20 From $3.25, Maintains Buy Rating	MT
28/03/23	Maxim Downgrades Venus Concept to Hold From Buy	MT
25/06/22	BTIG Research Adjusts Venus Concept Price Target to $5.50 From $7, Maintains Buy Rating	MT
17/06/22	Stifel Nicolaus Adjusts Venus Concept Price Target to $1 From $2, Maintains Hold Rating	MT

14/05	Venus Concept Announces Senior Management Changes	AQ
02/04	Venus Concept Announces Completion of Common Stock Sale and Short-Form Merger	AQ
21/01	Venus Concept Announces Intention to Voluntary Delist from Nasdaq and Deregister with SEC	AQ
13/11	Venus Concept: Q3 Earnings Snapshot	AQ
13/11	Venus Concept Announces Third Quarter 2025 Financial Results	AQ

Venus Concept Inc. Stock

Stocks

VERO

US92332W3034

Advanced Medical Equipment & Technology

Chart: Venus Concept Inc.

Latest news : Venus Concept Inc.

Last Transcript : Venus Concept Inc.

Analysts' recommendations : Venus Concept Inc.

Press Releases : Venus Concept Inc.

Quotes and Performance

Price Extremes

Managers and Directors : Venus Concept Inc.

Latest insider transactions

Other Advanced Medical Equipment & Technology

Company Profile

1 day	+2.56%
1 week	-0.00%
Current month	-0.00%
1 month	-0.00%
3 months	-0.00%
6 months	+0.16%
Current year	-79.02%

Current year	0.25	12.93
1 year	0.25	12.93
3 years	0.25	26.84
5 years	0.25	445.5
10 years	0.25	1,485

Manager	Title	Age	Since
Rajiv de Silva CEO	Chief Executive Officer	60	02/10/2022
Domenic della Penna DFI	Director of Finance/CFO	65	01/09/2017
Anat Kotler SAM	Sales & Marketing	-	-

Director	Title	Age	Since
Keith Sullivan BRD	Director/Board Member	67	01/07/2018
Louise Lacchin BRD	Director/Board Member	69	01/08/2015
Anthony Natale BRD	Director/Board Member	53	01/11/2019

Date	Insider	Type	Main position	Quantity	% Market Cap.
26/3/26	Essex Woodlands Management, Inc.	Sell	Company	0	0%
26/3/26	Essex Woodlands Management, Inc.	Sell	Company	3,075,810	59.2511%
26/3/26	Madryn Asset Management LP	Buy	Company	37,537,187	2,019.0803%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VENUS CONCEPT INC.	+2.56%	-0.00%	-86.53%	-98.34%	577K
THERMO FISHER SCIENTIFIC, INC.	-1.35%	-1.13%	+27.04%	+14.12%	230B
DANAHER CORPORATION	+0.18%	-1.27%	+5.25%	-17.37%	152B
INTUITIVE SURGICAL, INC.	+1.51%	-1.64%	-21.37%	+23.59%	132B
BOSTON SCIENTIFIC CORPORATION	+0.36%	-7.01%	-55.71%	-12.92%	67.88B
EDWARDS LIFESCIENCES CORPORATION	+0.29%	+0.47%	+11.06%	+18.65%	52B
SIEMENS HEALTHINEERS AG	+0.66%	-1.69%	-16.57%	-13.62%	51.05B
AGILENT TECHNOLOGIES, INC.	-2.44%	-3.25%	+23.11%	+28.29%	43.38B
WATERS CORPORATION	-1.56%	+0.97%	+39.32%	+47.34%	40.74B
ILLUMINA, INC.	-5.31%	-1.74%	+117.39%	+36.28%	32.55B
Average	-0.53%	-1.15%	+4.30%	+2.60%	80.12B
Weighted average by Cap.	-0.46%	-1.50%	+8.21%	+9.30%